: iStockAnalyst.com Symbols Feed

Gen-Probe Trims Guidance

Fri, 31 Jul 2009 13:42:49 GMT

Gen-Probe Inc. (GPRO) is a stock that has had an interesting year so far in 2009, with shares wildly swinging between $38 and $48. Shareholders of GPRO must wonder why the market’s impressive rally of the March lows has largely missed their stock as shares are only up 5% from the market’s nadir and GPRO is down 2% year to date. Judging by the market’s initial reaction to this firms second quarter earnings release, Friday is shaping up to be another wild day. Gen-Probe is in the business of making products that clinically test for human diseases. The company’s second quarter was not[More...]

Fewer Jobs Were Lost

Fri, 01 Aug 2008 15:53:00 GMT

Good morning. Investors are reacting to the jobs report where nonfarm payrolls fell by 51K in July (consenses expectations were at 70K) while the unemployment rate increased to 5.7% (a four-year high and above the 5.6% consensus expectation). Since Decemb[More...]

Few Thoughts and a Look at the Earnings in the Coming Week

Mon, 28 Jul 2008 05:15:00 GMT

WITH RESPECT TO THE US’ GDP GROWTH, THE NATIONAL BUREAU OF ECONOMIC RESEARCH SEES A SIGNIFICANT DECLINE IN ECONOMIC ACTITIVY SPREAD ACROSS THE ECONOMY, WHICH WILL LAST MORE THAN A FEW MONTHS - WSJ - According to Robert Hall, economist at Stanford University, US economic data that has been reported provide (...)[More...]

Market Moving Catalysts

Tue, 17 Jun 2008 13:58:41 GMT

Good morning. We have a lot of data to sort through this morning and so far premarket futures are positive in reaction to them.[More...]

What I like this morning: MDRX, GPRO

Fri, 15 Feb 2008 19:08:44 GMT

Couple of notable stocks:- Allscripts (NASDAQ:MDRX) is down 25% in pre mkt trading after reporting results that were below expectations. There is some pretty nasty analyst commentary out there with Deutsche cutting their rating and Piper Jaffray cutting...[More...]

Gen Probe (GPRO)

Wed, 08 Aug 2007 14:20:44 GMT

is the stock on WALLSTRIP this morning.[More...]

NASDAQ Technical Picture - Bullish Hammer after a Strong Close

Thu, 02 Aug 2007 05:38:56 GMT

It was a slow day until we got that strong finish. The bulls and bears struggled all day, but the last half hour gave[More...]

Novartis posts 62 pct rise in 4Q net profit

Wed, 28 Jan 2009 11:50:00 GMT

BASEL, Switzerland - Drugmaker Novartis AG reported a 62 percent rise in fourth quarter net profit Wednesday, helped by steady sales growth and the absence of the restructuring charges that hindered the previous year's results.
The company said net income rose to $1.507 billion from $931 million in the fourth quarter of 2007.
For the full year 2008 Novartis said its net income from continuing operations rose 25 percent to $8.163 billion from $6.540 billion.

[More...]

Gen-Probe Begins U.S. Clinical Study of PROGENSA(R) PCA3 Assay, New Molecular Test to Help Assess Prostate Cancer Risk

Thu, 27 Aug 2009 19:56:00 GMT

Gen-Probe Incorporated announced today that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.[More...]

Gen-Probe Begins U.S. Clinical Study of APTIMA(R) Trichomonas Vaginalis Assay on the TIGRIS(R) System

Mon, 17 Aug 2009 19:59:00 GMT

Gen-Probe Incorporated announced today that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its APTIMA) assay for Trichomonas vaginalis on the fully automated TIGRIS) system.[More...]

Gen-Probe Broadens Intellectual Property Portfolio Surrounding Automated Nucleic Acid Testing

Tue, 04 Aug 2009 19:56:00 GMT

Gen-Probe Incorporated announced today that it recently has been granted seven additional patents by the U.S. and European patent authorities that extend the Company's intellectual property estate related to automated instrument systems for nucleic acid testing .[More...]

Gen-Probe to Webcast Presentation at the Canaccord Adams 29th Annual Global Growth Conference

Mon, 03 Aug 2009 21:31:00 GMT

Gen-Probe Incorporated announced today that the Company will present at the Canaccord Adams 29th Annual Global Growth Conference on Tuesday, August 11, 2009 at 2:30 p.m. Eastern time . The presentation is scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website at www.gen-probe.com. The webcast will be available for 30 days following the event.[More...]

Gen-Probe Reports Financial Results for Second Quarter 2009

Thu, 30 Jul 2009 19:57:00 GMT

Gen-Probe Incorporated today reported financial results for the second quarter of 2009, including non-GAAP earnings per share of $0.45 and record sexually transmitted disease , clinical diagnostics and total product sales.[More...]

Gen-Probe Announces Webcast of Second Quarter 2009 Earnings Conference Call

Mon, 13 Jul 2009 10:57:00 GMT

Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will release its second quarter 2009 financial results on Thursday, July 30, 2009 at approximately 4:00 p.m. Eastern Time (ET). The announcement will be followed by a conference call with management at 4:30 p.m. ET.[More...]